CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
76.41
-0.62 (-0.80%)
Aug 12, 2026, 3:50 PM EDT - Market open
CG Oncology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 19.64 | 32.49 | 257.07 | 8.27 | 88.14 | 88.14 |
Short-Term Investments | 1,009 | 709.67 | 484.93 | 179.41 | 55.34 | 55.34 |
Cash & Short-Term Investments | 1,028 | 742.16 | 742 | 187.67 | 143.48 | 143.48 |
Cash Growth | 55.55% | 0.02% | 295.37% | 30.80% | 0% | - |
Accounts Receivable | 0.42 | 0.69 | - | - | - | - |
Other Receivables | - | - | - | 0.09 | 0.3 | 0.3 |
Total Trade Receivables | 0.42 | 0.69 | - | 0.09 | 0.3 | 0.3 |
Inventory | 1 | 1.57 | - | - | - | - |
Other Current Assets | 19.95 | 15.07 | 12.21 | 6.36 | 3.42 | 3.42 |
Total Current Assets | 1,050 | 759.48 | 754.21 | 194.12 | 147.21 | 147.21 |
Net Property, Plant & Equipment | 20.44 | 19.57 | 0.49 | 0.49 | 0.51 | 0.51 |
Other Intangible Assets | 0.55 | 0.58 | - | - | - | - |
Goodwill | 10.3 | 10.3 | - | - | - | - |
Other Long-Term Assets | 4.73 | 1.68 | 0.09 | 4.69 | 0.03 | 0.03 |
Total Assets | 1,086 | 791.59 | 754.8 | 199.3 | 147.75 | 147.75 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 12.73 | 5.71 | 6.52 | 3.24 | 0.99 | 0.99 |
Accrued Expenses | 33.53 | 24.21 | 14.67 | 10.44 | 5.29 | 5.29 |
Current Portion of Long-Term Debt | - | - | - | - | 8.97 | 8.97 |
Current Portion of Leases | 0.99 | 0.92 | 0.19 | 0.22 | 0.19 | 0.19 |
Other Current Liabilities | - | - | - | 0.35 | - | - |
Total Current Liabilities | 47.24 | 30.84 | 21.37 | 14.25 | 15.43 | 15.43 |
Long-Term Debt | 3 | 3 | - | - | 6.53 | 6.53 |
Long-Term Leases | 4.83 | 3.11 | 0.05 | 0.24 | 0.26 | 0.26 |
Other Long-Term Liabilities | 1.46 | 2.05 | - | 0.01 | 0.35 | 0.35 |
Total Long-Term Liabilities | 9.3 | 8.15 | 0.05 | 0.26 | 7.14 | 7.14 |
Total Liabilities | 56.54 | 38.99 | 21.42 | 14.51 | 22.57 | 22.57 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Additional Paid-in Capital | 1,547 | 1,132 | 951.35 | 6.84 | 3.64 | 3.64 |
Retained Earnings | -518.23 | -378.98 | -217.98 | -129.94 | -81.34 | -81.34 |
Total Common Shareholders' Equity | 1,029 | 752.6 | 733.38 | -123.1 | -77.69 | -77.69 |
Minority Interest | - | - | - | 307.89 | 202.87 | 82.87 |
Shareholders' Equity | 1,029 | 752.6 | 733.38 | 184.79 | 125.18 | 5.18 |
Total Liabilities & Equity | 1,086 | 791.59 | 754.8 | 199.3 | 147.75 | 147.75 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 8.82 | 7.02 | 0.24 | 0.46 | 15.94 | 15.94 |
Net Cash (Debt) | 1,019 | 735.13 | 741.76 | 187.21 | 127.54 | 127.54 |
Net Cash Growth | 54.45% | -0.89% | 296.21% | 46.79% | 0% | - |
Net Cash Per Share | 12.38 | 9.51 | 11.87 | 43.23 | 34.09 | 34.94 |
Book Value | 1,029 | 752.6 | 733.38 | -123.1 | -77.69 | -77.69 |
Book Value Per Share | 12.49 | 9.74 | 11.73 | -28.42 | -20.77 | -21.28 |
Tangible Book Value | 1,018 | 741.73 | 733.38 | -123.1 | -77.69 | -77.69 |
Tangible Book Value Per Share | 12.36 | 9.60 | 11.73 | -28.42 | -20.77 | -21.28 |